Navigation Links
Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
Date:5/26/2010

gressive step to take at this point," said Jeffrey Kindler, Pfizer's chairman and chief executive officer.

The newly named Pfizer Worldwide Research & Development organization will maintain an R&D structure that supports excellence in small molecules, large molecules and vaccine research and development.  It will include biotherapeutics research and development, focused on large molecules and biotechnologies; pharmatherapeutics research and development, focused on small molecules; and vaccines research and development.  Pfizer adopted a novel R&D model following the Wyeth acquisition to foster diversity of talent, assets and culture, as well as the empowerment and accountability of research leaders across R&D.  Pfizer initially implemented this model with a two-division structure (BioTherapeutics and PharmaTherapeutics) to ensure the progress and steady integration of both legacy organizations.  Due to the speed and effectiveness of the integration, Pfizer is now able to implement a diversified R&D platform with the same breadth and research programs, under the consolidated leadership of Dr. Dolsten.

"Mikael Dolsten is an exceptional scientist who is highly regarded and committed to bringing new preventative measures, treatments and cures to people.  Mikael's scientific expertise, vision for R&D and commercial mindset have distinguished him at Pfizer and uniquely qualify him to lead our R&D colleagues and advance our pipeline.  Having all of Pfizer's research conducted under Mikael's leadership will enrich the alignment between our research programs and commercial teams to address important unmet medical needs and deliver the next generation of medicines," said Mr. Kindler.  

"I am excited to have the opportunity to align the tremendous science that is in every corner of Pfizer t
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... LONDON , July 14, 2014  VirtualScopics, Inc. ... IXI) jointly announced today the formation of a Scientific ... Edward Ashton , Ph.D., chief scientific officer, VirtualScopics, will ... "The formation of this joint Scientific Advisory ... and operational alliance we signed with IXICO plc on ...
(Date:7/13/2014)... 2014 Auf seiner ... veranstalteten F&E-Tagung meldete Astellas Fortschritte ... seines Forschungsrahmenprogramms. Die Tagung bot Astellas die ... klinischen Programme und die Konzernstrategie des Unternehmens ... darin, aktuelle Meldungen zu den Astellas-Initiativen in ...
(Date:7/13/2014)... , July 13, 2014  Eli Lilly ... announced results from its non-clinical study in genetically ... version of the beta-amyloid antibody N3pG and beta-secretase ... therapy was more effective in removing clumps of ... that is thought to lead to Alzheimer,s disease ...
Breaking Medicine Technology:VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 2VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 3VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 4VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 5VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 6VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 7VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 8VirtualScopics, Inc. And IXICO plc Announce The Formation Of A Scientific Advisory Board To Benefit Both Companies; Dr. Edward Ashton, Ph.D. Appointed Chairman 9Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 2Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 3Astellas erörtert Pipeline-Fortschritte auf F&E-Tagung 4New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3
... Roche NimbleGen (SIX: RO, ROG; Pink Sheets: RHHBY ... genomic services provider Ambry Genetics has officially become a ... EZ Exome workflow. They will provide target-enrichment services ... sequencing services for genetic research. Ambry Genetics has passed ...
... Luminex Corporation (Nasdaq: LMNX ) today announced ... Conference to be held September 20 - 22, 2010, ...   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) (Logo:   http://www.newscom.com/cgi-bin/prnh/20100104/LUMINEXLOGO ) ... president and chief executive officer, will begin at 8:00 ...
Cached Medicine Technology:Ambry Genetics Becomes First Certified Service Provider in US for NimbleGen SeqCap EZ Exome 2Ambry Genetics Becomes First Certified Service Provider in US for NimbleGen SeqCap EZ Exome 3Luminex Corporation to Present at UBS Global Life Sciences Conference 2
(Date:7/14/2014)... AttorneyOne.com, a recognized authority on law, update ... the FDA on Hospira Lactated Ringer’s and 5% ... 11, that one lot of Lactated Ringers and 5% ... Inc., is recalled due to mold contamination. The specific ... of fluid and electrolytes, with or without minimal carbohydrate ...
(Date:7/14/2014)... EurekaMag.com has newly published results of 64,900 ... disease that ranges in severity from a mild ... illness that attacks the liver. An estimated 3.2 million ... virus infection of which approximately 80% of people develop ... all studies on Hepatitis C , the Life, Earth ...
(Date:7/14/2014)... Wa (PRWEB) July 14, 2014 According to ... this is a helpful guide that features a series of ... exposes in its review that this book can help readers ... causes of high blood pressure, and effective methods to ... they are reviewed now by Vkool, was penned by Ken ...
(Date:7/14/2014)... Seattle, Wa (PRWEB) July 14, 2014 ... And Violet Protocol book review recently updated ... that consists of a wide range of ... symptoms of endometriosis including:, ...     Avoiding meat and dairy products , ...
(Date:7/14/2014)... (PRWEB) July 14, 2014 According to the Boost ... helpful book for women who want to learn how to increase ... This book consists of 7 chapters including:, , ... Grow? , Chapter 2 – How Natural Breast Enlargement ... Your Breasts Look Bigger , Chapter 4 – The ...
Breaking Medicine News(10 mins):Health News:Hospira Lactated Ringer’s and 5% Dextrose Injection Recalled: AttorneyOne Monitor and Keep Consumers Informed 2Health News:Hospira Lactated Ringer’s and 5% Dextrose Injection Recalled: AttorneyOne Monitor and Keep Consumers Informed 3Health News:EurekaMag.com Publishes 64,900 New Studies on Hepatitis C 2Health News:Blood Pressure Solution Book Review Exposes Ken Burge's Hypertension Treatment Guide – Vkool.com 2Health News:Blood Pressure Solution Book Review Exposes Ken Burge's Hypertension Treatment Guide – Vkool.com 3Health News:Endometriosis Bible and Violet Protocol Book Review Exposes Zoe Brown's Endometriosis Treatment Guide – Vkool.com 2Health News:Endometriosis Bible and Violet Protocol Book Review Exposes Zoe Brown's Endometriosis Treatment Guide – Vkool.com 3Health News:Boost Your Bust Book Review Exposes Jenny Bolton's Breast Enhancement Guide – Vkool.com 2Health News:Boost Your Bust Book Review Exposes Jenny Bolton's Breast Enhancement Guide – Vkool.com 3
... , , , ... Michael Jackson,s death, reports of anxiety, depression, insomnia and fatigue have ... his reliance on prescription drugs. But Beverly Hills anti-aging consultants Karen ... Jackson could have been suffering from male menopause for years. You ...
... NANJING, China, Aug. 5 /PRNewswire-Asia/ -- Simcere Pharmaceutical ... supplier of branded generic and,innovative anti-cancer pharmaceuticals in China, ... quarter results on Monday, August 17, 2009,after the market ... Ren, and chief financial officer, Frank Zhigang Zhao, will,host ...
... ATHLETES SARAH WILL AND CHRIS WADDELL TO RIDE ON SEPT. ... of the greatest Paralympic athletes in the world have signed on to ... and Sarah Will both plan to ride in the event, raising money ... , , Waddell and Will join over a dozen ...
... , , SAN FRANCISCO, Aug. ... depression, according to a study just published in the Journal ... to higher risk for poor health outcomes and complications from ... of an ongoing study of healthy adults aged 65 and ...
... ... ... -- United Benefit Advisors (UBA), in partnership with the National Association of Health Underwriters (NAHU), ... regarding what,s happening now in the national health care reform debate., , , , ,Janet ...
... , ARLINGTON, Va., Aug. 5 ... service, and KnujOn.com , an Internet compliance ... (online advertisements) for Internet pharmacies displayed on bing.com. The report ... by the authors were fake or illegal Internet pharmacies. , ...
Cached Medicine News:Health News:SimplyAgeless Believes Michael Jackson Could Have Been Going Through 'Male Menopause' 2Health News:Simcere Pharmaceutical Group to Announce 2009 Second Quarter Earnings on Monday, August 17, 2009 2Health News:Celebrity Paralympians Sign on to Kelly Brush Century Ride 2Health News:Celebrity Paralympians Sign on to Kelly Brush Century Ride 3Health News:Brain Fitness Reduces Risk of Onset of Depressive Symptoms 2Health News:UBA offers Free Webinar: NAHU Executive VP and CEO to Discuss Health Reform Bills 2Health News:UBA offers Free Webinar: NAHU Executive VP and CEO to Discuss Health Reform Bills 3Health News:Report: Microsoft Sponsoring Ads for Rogue Internet Pharmacies 2
... Easy Breeze Air Gel Dryer : Dry up ... 24 gels 8 10 cm without a ... rapid drying, or no heat for controlled drying ... transparent, dried gels. Add and remove gels at ...
Each GelAir™ system drying frame includes two main components, a plastic drying outer frame and a metal square inner frame, as well as 8 clamps per frame. Supplied as a set of two frames....
... Breeze Air Gel Dryer : Dry up to ... gels 8 10 cm without a vacuum ... drying, or no heat for controlled drying of ... dried gels. Add and remove gels at any ...
... SGD5040 Slab Gel Dryer incorporates sturdy metal housing and ... The large surface area makes it perfect for drying ... Slim Profile 40cm x 50cm (W x D) ... Rates allows you to optimize your heating ...
Medicine Products: